Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

COAGCOAG
1 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in HEMAB THERAPEUTICS HOLDI

Yes. Citadel Advisors holds 523,450 shares of COAG (Hemab Therapeutics Holdi), worth $19.2M, as of its Q2 2026 13F filing.

Current Value

$19.2M

Current Shares

523,450

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
523,450
-
$19.2M0.0%$36.73
39

Other major holders of COAG: RA CAPITAL MANAGEMENT, L.P., FMR LLC, Capital International Investors, Avoro Capital Advisors LLC, JPMORGAN CHASE & CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used